RaySearch Laboratories AB (publ) (RAY-B.ST)
SEK 205.0
(1.49%)
SEK 205.0
(1.49%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.02 Billion SEK | 21.16% |
| 2022 | 843.64 Million SEK | 31.48% |
| 2021 | 641.67 Million SEK | -1.53% |
| 2020 | 651.61 Million SEK | -12.13% |
| 2019 | 741.58 Million SEK | 18.23% |
| 2018 | 627.21 Million SEK | 7.2% |
| 2017 | 585.08 Million SEK | 10.09% |
| 2016 | 531.46 Million SEK | 33.67% |
| 2015 | 397.6 Million SEK | 39.4% |
| 2014 | 285.21 Million SEK | 39.49% |
| 2013 | 204.47 Million SEK | 12.29% |
| 2012 | 182.08 Million SEK | 44.4% |
| 2011 | 126.1 Million SEK | 7.11% |
| 2010 | 117.72 Million SEK | 40.68% |
| 2009 | 83.68 Million SEK | 33.49% |
| 2008 | 62.69 Million SEK | -3.11% |
| 2007 | 64.7 Million SEK | -6.19% |
| 2006 | 68.97 Million SEK | -1.26% |
| 2005 | 69.85 Million SEK | 76.94% |
| 2004 | 39.47 Million SEK | 78.28% |
| 2003 | 22.14 Million SEK | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 318.86 Million SEK | 23.98% |
| 2024 Q1 | 257.19 Million SEK | -14.16% |
| 2023 FY | 1.02 Billion SEK | 21.16% |
| 2023 Q3 | 252.88 Million SEK | 5.6% |
| 2023 Q2 | 239.46 Million SEK | 4.04% |
| 2023 Q1 | 230.16 Million SEK | -12.94% |
| 2023 Q4 | 299.64 Million SEK | 18.49% |
| 2022 Q4 | 264.38 Million SEK | 25.37% |
| 2022 Q2 | 160.23 Million SEK | -23.02% |
| 2022 Q1 | 208.14 Million SEK | 10.38% |
| 2022 FY | 843.64 Million SEK | 31.48% |
| 2022 Q3 | 210.88 Million SEK | 31.61% |
| 2021 Q3 | 136.41 Million SEK | -11.75% |
| 2021 FY | 641.67 Million SEK | -1.53% |
| 2021 Q1 | 162.1 Million SEK | 1.42% |
| 2021 Q4 | 188.57 Million SEK | 38.23% |
| 2021 Q2 | 154.57 Million SEK | -4.64% |
| 2020 Q2 | 163.75 Million SEK | -21.61% |
| 2020 Q1 | 208.88 Million SEK | -10.92% |
| 2020 Q4 | 159.83 Million SEK | 34.17% |
| 2020 FY | 651.61 Million SEK | -12.13% |
| 2020 Q3 | 119.13 Million SEK | -27.25% |
| 2019 Q3 | 144.34 Million SEK | -23.89% |
| 2019 Q2 | 189.65 Million SEK | 9.58% |
| 2019 Q4 | 234.49 Million SEK | 62.45% |
| 2019 FY | 741.58 Million SEK | 18.23% |
| 2019 Q1 | 173.07 Million SEK | -21.13% |
| 2018 FY | 627.21 Million SEK | 7.2% |
| 2018 Q4 | 219.44 Million SEK | 45.83% |
| 2018 Q3 | 150.48 Million SEK | 6.69% |
| 2018 Q2 | 141.03 Million SEK | 21.32% |
| 2018 Q1 | 116.25 Million SEK | -43.28% |
| 2017 FY | 585.08 Million SEK | 10.09% |
| 2017 Q1 | 126.78 Million SEK | -33.74% |
| 2017 Q3 | 111.7 Million SEK | -21.13% |
| 2017 Q2 | 141.63 Million SEK | 11.71% |
| 2017 Q4 | 204.96 Million SEK | 83.49% |
| 2016 Q1 | 95.4 Million SEK | -27.7% |
| 2016 FY | 531.46 Million SEK | 33.67% |
| 2016 Q2 | 118.98 Million SEK | 24.72% |
| 2016 Q3 | 125.73 Million SEK | 5.67% |
| 2016 Q4 | 191.35 Million SEK | 52.2% |
| 2015 FY | 397.6 Million SEK | 39.4% |
| 2015 Q3 | 100.57 Million SEK | 30.03% |
| 2015 Q4 | 131.95 Million SEK | 31.21% |
| 2015 Q2 | 77.34 Million SEK | -11.84% |
| 2015 Q1 | 87.73 Million SEK | -18.6% |
| 2014 Q2 | 51.85 Million SEK | -3.93% |
| 2014 FY | 285.21 Million SEK | 39.49% |
| 2014 Q4 | 107.78 Million SEK | 50.53% |
| 2014 Q3 | 71.6 Million SEK | 38.08% |
| 2014 Q1 | 53.97 Million SEK | -40.1% |
| 2013 Q4 | 90.11 Million SEK | 131.31% |
| 2013 FY | 204.47 Million SEK | 12.29% |
| 2013 Q3 | 38.95 Million SEK | 41.66% |
| 2013 Q2 | 27.5 Million SEK | -42.59% |
| 2013 Q1 | 47.9 Million SEK | -37.69% |
| 2012 Q1 | 38.44 Million SEK | -16.0% |
| 2012 Q3 | 40.2 Million SEK | 51.39% |
| 2012 Q2 | 26.55 Million SEK | -30.93% |
| 2012 FY | 182.08 Million SEK | 44.4% |
| 2012 Q4 | 76.87 Million SEK | 91.23% |
| 2011 Q2 | 24.52 Million SEK | 6.4% |
| 2011 Q3 | 32.76 Million SEK | 33.59% |
| 2011 Q4 | 45.77 Million SEK | 39.71% |
| 2011 FY | 126.1 Million SEK | 7.11% |
| 2011 Q1 | 23.04 Million SEK | -33.69% |
| 2010 Q4 | 34.75 Million SEK | 57.55% |
| 2010 FY | 117.72 Million SEK | 40.68% |
| 2010 Q3 | 22.06 Million SEK | -32.83% |
| 2010 Q2 | 32.84 Million SEK | 17.05% |
| 2010 Q1 | 28.06 Million SEK | -22.83% |
| 2009 Q1 | 16.93 Million SEK | 0.0% |
| 2009 Q3 | 12.66 Million SEK | -28.58% |
| 2009 FY | 83.68 Million SEK | 33.49% |
| 2009 Q4 | 36.36 Million SEK | 187.24% |
| 2009 Q2 | 17.72 Million SEK | 4.66% |
| 2008 FY | 62.69 Million SEK | -3.11% |
| 2007 FY | 64.7 Million SEK | -6.19% |
| 2006 FY | 68.97 Million SEK | -1.26% |
| 2005 FY | 69.85 Million SEK | 76.94% |
| 2004 FY | 39.47 Million SEK | 78.28% |
| 2003 FY | 22.14 Million SEK | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Aino Health AB (publ) | 23.91 Million SEK | -4173.419% |
| Bonzun AB (publ) | 2.73 Million SEK | -37259.804% |
| Kontigo Care AB (publ) | 28.94 Million SEK | -3431.018% |
| Medhelp Care Aktiebolag (publ) | 84.08 Million SEK | -1115.655% |
| Surgical Science Sweden AB (publ) | 882.85 Million SEK | -15.779% |